Safety and Immunomodulatory Effects of Three Probiotic Strains Isolated from the Feces of Breast-Fed Infants in Healthy Adults: SETOPROB Study

Abstract

We previously described the isolation and characterization of three probiotic strains from the feces of exclusively breast-fed newborn infants: Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036. These strains were shown to adhere to intestinal mucus in vitro, to be sensitive to antibiotics and to resist biliary salts and low pH. In the present study, a multicenter, randomized, double-blind, placebo-controlled trial with 100 healthy volunteers in three Spanish cities was carried out to evaluate the tolerance, safety, gut colonization and immunomodulatory effects of these three probiotics. Volunteers underwent a 15-day washout period, after which they were randomly divided into 5 groups that received daily a placebo, a capsule containing one of the 3 strains or a capsule containing a mixture of two strains for 30 days. The intervention was followed by another 15-day washout period. Patients did not consume fermented milk for the entire duration of the study. Gastrointestinal symptoms, defecation frequency and stool consistency were not altered by probiotic intake. No relevant changes in blood and serum, as well as no adverse events occurred during or after treatment. Probiotic administration slightly modified bacterial populations in the volunteers’ feces. Intestinal persistence occurred in volunteers who received L. rhamnosus CNCM I-4036. Administration of B. breve CNCM I-4035 resulted in a significant increase in fecal secretory IgA content. IL-4 and IL-10 increased, whereas IL-12 decreased in the serum of volunteers treated with any of the three strains. These results demonstrate that the consumption of these three bacterial strains was safe and exerted varying degrees of immunomodulatory effects.Trial RegistrationClinicalTrials.gov NCT01479543

The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases

“…It has been demonstrated that probiotics can affect the structure of gut microbiota and the interaction with the microbial community and the host health through different mechanisms [12,[193][194][195]. These effects are mediated by the direct or indirect action of probiotics and can involve the modulation of the immune system or that of remote organs like the brain and liver due to the production of metabolites finally localized in these organs [193,[196][197][198][199].…”

Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on Hepatic Steatosis in Zucker Rats

“…Oral administration of these LAB strains modified the bacterial populations in the feces of the volunteers, and all three strains exerted varying degrees of immunomodulatory effects [20]. Thus, administration of B. breve CNCM I-4035 resulted in a significant increase in fecal secretory IgA content.…”

Complete Genome Sequence of the Probiotic Strain Lactobacillus salivarius LPM01

“…Results highlighting the functional effect of some probiotics in boosting the immune system (3) have led to the attempt to study the effect of probiotics on the amelioration of immunosupression therapy side effects.…”